The ROC analysis in Table 3 shows that the ability to distinguish NSCLC patients from healthy controls using RRM2 was 0.798 (95% confidence interval (CI) 0.731–0.866) and the cut-off value was 131.31 ng/mL. Here, RRM2 is linked to non-small cell lung carcinoma.